Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Type of study
Publication year range
1.
J Steroid Biochem Mol Biol ; 73(1-2): 67-70, 2000 May.
Article in English | MEDLINE | ID: mdl-10822026

ABSTRACT

Gross cystic breast disease (GCBD) is common in women, especially in the age range between 35 and the menopausal years. The present study examined the possible role of progesterone (Pg) in the chorionic gonadotropin (hCG) concentration in GCBD. The breast cyst fluids (BCFs) were drawn by fine needle aspiration between the sixth and the eighth day of the menstrual cycle and twenty days later. On the day of the first aspiration the patient began to take 100 mg of natural micronized Pg orally until the second aspiration. At both times blood samples were also taken. Determinations were done of both BCFs and blood sample using two fully automated chemiluminiscent enzyme immunometric assays. Pg has been demonstrated to induce a significant increment in hCG + free ss-hCG (median, range): 0.27 ng/ml, 0.12-6.24 vs. 1.92 ng/ml, 0.12-423.5; free ss-hCG: 0.11 ng/ml, 0.02-2.40 vs. 0.91 ng/ml, 0.02-58.40 in the BCFs, with no change in the circulating concentrations of the hormone. None of the sera studied presented levels of hCG + free ss-hCG or free ss-hCG above 0.5 ng/ml or 0.1 ng/ml, respectively. The occurrence of hCG or a derivative polypeptide in BCFs, when they are present in high concentrations suggests that this glycoprotein could be synthesized in situ and possibly involved in the pathogenesis of GCBD by the degree of differentiation of breast epithelial cells induced by the hormone.


Subject(s)
Chorionic Gonadotropin/metabolism , Cyst Fluid/drug effects , Cyst Fluid/metabolism , Fibrocystic Breast Disease/drug therapy , Fibrocystic Breast Disease/metabolism , Progesterone/administration & dosage , Administration, Oral , Adult , Chorionic Gonadotropin/blood , Chorionic Gonadotropin, beta Subunit, Human/blood , Chorionic Gonadotropin, beta Subunit, Human/metabolism , Epithelium/metabolism , Female , Fibrocystic Breast Disease/etiology , Humans
2.
Breast Cancer Res Treat ; 24(1): 1-9, 1992.
Article in English | MEDLINE | ID: mdl-1463866

ABSTRACT

Gross cystic disease of the breast may sometimes indicate an increased risk of breast cancer. Biochemical analysis of the cyst fluid could suggest which cysts are associated with breast cancer risk, as well as providing insights into the pathophysiology of this condition. The Na+/K+ ratio appears to be associated with the histological classification of the cyst. Sulfoconjugated estrogens and androgens, especially DHEA-S, are often found at high levels. A number of gross cystic disease fluid proteins (GCDFPs) have been described, and several polypeptide growth factors including EGF and IGF-I are frequently found. It is hoped that biochemical analysis of these components of breast cyst fluids will shed further light on the role of gross cysts in relation to breast cancer.


Subject(s)
Apolipoproteins , Exudates and Transudates/chemistry , Fibrocystic Breast Disease/metabolism , Membrane Transport Proteins , Androgens/analysis , Apolipoproteins D , Bile Acids and Salts/analysis , Carrier Proteins/analysis , Estrogens/analysis , Female , Glycoproteins/analysis , Growth Substances/analysis , Humans , Proteins/analysis
5.
SELECTION OF CITATIONS
SEARCH DETAIL
...